Status:
COMPLETED
Effect of Feedings on Caffeine in Premature Infants
Lead Sponsor:
Duke University
Collaborating Sponsors:
University of North Carolina, Chapel Hill
Conditions:
Apnea of Prematurity
Premature Newborn
Eligibility:
All Genders
Up to 15 years
Brief Summary
Almost all infants born \<29 weeks gestational age develop apnea of prematurity and are treated with caffeine. Type of diet and disease states may be significant contributors of variability in caffein...
Detailed Description
This study will use a consecutive patient sampling approach. All eligible participants admitted at each site will be approached. Caffeine and feedings will be administered per standard of care. Manipu...
Eligibility Criteria
Inclusion
- Written informed consent from parent(s) or legal guardian(s)
- \<29 weeks birth gestational age
- Postnatal age ≤15 days
- Receiving caffeine (intravenous or oral) per standard of care for prevention or treatment of apnea of prematurity
Exclusion
- Known major congenital or chromosomal anomaly
Key Trial Info
Start Date :
December 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 30 2017
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT02293824
Start Date
December 1 2014
End Date
June 30 2017
Last Update
September 13 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
North Carolina Children's Hospital
Chapel Hill, North Carolina, United States, 27599
2
Duke University Medical Center
Durham, North Carolina, United States, 27710